Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New remote oxygen monitoring could protect fragile preterm lungs

NCT ID NCT07161908

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 27 times

Summary

This study tests a remote monitoring system to better manage oxygen therapy in premature infants born before 32 weeks who have bronchopulmonary dysplasia. The goal is to reduce health complications by optimizing oxygen levels and shortening the time babies need oxygen support. About 70 infants will participate across multiple hospitals in the Czech Republic.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • General University Hospital

    RECRUITING

    Prague, Czech Republic, Czechia

    Contact Email: •••••@•••••

  • Institute for the Care of Mother and Child

    RECRUITING

    Prague, Czech Republic, Czechia

    Contact Email: •••••@•••••

  • University Hospital Olomouc

    RECRUITING

    Olomouc, Czech Republic, Czechia

    Contact Email: •••••@•••••

  • České Budějovice Hospital

    RECRUITING

    České Budějovice, Czech Republic, Czechia

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

bronchopulmonary dysplasia pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.